 ft 20 92 intern compani news astra surg strong losec sale  astra swedish pharma ceutic compani boost pre tax profit 40 cent skr1 063bn dollar 185 2m quarter 1992 skr757m period 1991 compani forecast profit full year rise 20 25 cent skr4bn sale quarter climb 35 cent skr3 7bn skr2 7bn profit share rose 45 cent skr5 55 skr3 85 sale losec compani high success stomach ulcer drug main competitor glaxo zantac increas 72 cent quarter skr991m skr577m biggest market germani franc britain total sale losec includ made licenc holder itali spain reach skr1 550bn skr880m astra asthma agent pulmicort enjoy 57 cent sale increas quarter skr414m skr264 